Trial intelligence / Profile preview

Cisplatin Induction with Paclitaxel Consolidation in Ovarian Cancer

NCT00314678Phase 2Completed

Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of topotecan in epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC). Started Sep 2005; status: completed.

02

Drugs

topotecan
03

Conditions

epithelial ovarian cancer (EOC)primary peritoneal cancer (PPC)

Beyond the preview

Go deeper on NCT00314678.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00314678.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call